RT Journal Article SR Electronic T1 The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers JF Thorax JO Thorax FD BMJ Publishing Group Ltd and British Thoracic Society SP thoraxjnl-2017-210473 DO 10.1136/thoraxjnl-2017-210473 A1 Nicola J Rowbotham A1 Sherie Smith A1 Paul A Leighton A1 Oli C Rayner A1 Katie Gathercole A1 Zoe C Elliott A1 Edward F Nash A1 Tracey Daniels A1 Alistair J A Duff A1 Sarah Collins A1 Suja Chandran A1 Ursula Peaple A1 Matthew N Hurley A1 Keith Brownlee A1 Alan R Smyth YR 2017 UL http://thorax.bmj.com/content/early/2017/08/04/thoraxjnl-2017-210473.abstract AB There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research should focus on questions which are most important to the CF community. We conducted a James Lind Alliance Priority Setting Partnership in CF. Research questions were elicited and then prioritised in successive surveys. A workshop agreed the final top 10. Online methods avoided cross infection and widened participation. The elicitation survey had 482 respondents (1080 questions) and prioritisation survey 677 respondents. Participants were drawn equally from the patient and clinical communities globally. We have achieved a consensus on 10 research priorities which will be attractive to funders.